218 / 1631
CVD after therapy for
HL:
A detailed analysis of
9 collaborative
EORTC-LYSA trials
Maraldo et al, Lancet Hemat 2015
Dead: 816 patients
EORTC database:
6675
patients
Life Situation Questionnaire
(LSQ): 4735 patients eligible
Clinical report forms:
6039
patients
Not Hodgkin lymphoma:
10 patients
Entered into both early
and advanced stage trials:
7 patients
Non-participating centers:
739 patients
Incomplete treatment
information: 566 patients
LSQ responders:
1919
patients
Address unavailable:
1073 patients
PROSPECTIVE
RETROSPECTIVE
LSQ refusal/no-response:
1004 patients
Dead: 488 patients
Follow-up data not
available: 53 patients